GlassScriptPhysician profile
Sonal Patel
NPI 1538603014
$745.86
in general payments reported to CMS, 2019-2025
15 companies · $74.89 in 2025
The $74.89 reported for 2025 was less than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $555 · 2022: $51.33 · 2023: $64.93 · 2025: $74.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $139.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $198.31 | 2021-2022 | |
| Pfizer INC. | $130.05 | 2021 | |
| Supernus Pharmaceuticals, INC. | $112.49 | 2021 | |
| Nestle Healthcare Nutrition INC. | $53.66 | 2021 | |
| Merck Sharp & Dohme LLC | $35.68 | 2021 | |
| Abbott Laboratories | $31.28 | 2025 | Id Now Instrument |
| Glaxosmithkline, LLC. | $27.60 | 2023 | Bexsero, Pediarix |
| Sanofi Pasteur INC. | $22.59 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $21.80 | 2021 | |
| Seqirus USA INC | $21.02 | 2025 | Flucelvax |
| Bioventus LLC | $20.58 | 2022 | |
| Phadia US INC. | $20.00 | 2023 | Immunocap |
| Genzyme Corporation | $18.88 | 2021 | |
| Cranial Technologies, INC | $17.33 | 2023 | Doc Band |
| Kyowa Kirin, INC. | $14.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.